Response to pneumococcal vaccine in the elderly

No enhancement by indomethacin

William P. Lafferty, Daniel S. Selinger, Gerald Schiffman, James Goodwin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We investigated whether indomethacin administration would augment the antibody response to pneumococcal vaccine in a group of healthy elderly individuals. There was no significant difference in mean increases in antibody levels to 12 pneumococcal polysaccharide types between the 20 subjects who received indomethacin 25 mg q.i.d. for five days after immunization and the control subjects not receiving indomethacin. In addition, there was no correlation within this group of 40 individuals between three measures of immune function (absolute lymphocyte count, delayed hypersensitivity testing, and response to phytohemagglutinin) and the antibody response to the pneumococcal vaccine.

Original languageEnglish
Pages (from-to)241-250
Number of pages10
JournalImmunopharmacology and Immunotoxicology
Volume3
Issue number2
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Pneumococcal Vaccines
Indomethacin
Antibody Formation
Antibodies
Immunization
Lymphocytes
Delayed Hypersensitivity
Lymphocyte Count
Phytohemagglutinins
Polysaccharides
Testing

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology
  • Toxicology

Cite this

Response to pneumococcal vaccine in the elderly : No enhancement by indomethacin. / Lafferty, William P.; Selinger, Daniel S.; Schiffman, Gerald; Goodwin, James.

In: Immunopharmacology and Immunotoxicology, Vol. 3, No. 2, 1981, p. 241-250.

Research output: Contribution to journalArticle

Lafferty, William P. ; Selinger, Daniel S. ; Schiffman, Gerald ; Goodwin, James. / Response to pneumococcal vaccine in the elderly : No enhancement by indomethacin. In: Immunopharmacology and Immunotoxicology. 1981 ; Vol. 3, No. 2. pp. 241-250.
@article{31dd4658e3644963a3b205dd92a42cad,
title = "Response to pneumococcal vaccine in the elderly: No enhancement by indomethacin",
abstract = "We investigated whether indomethacin administration would augment the antibody response to pneumococcal vaccine in a group of healthy elderly individuals. There was no significant difference in mean increases in antibody levels to 12 pneumococcal polysaccharide types between the 20 subjects who received indomethacin 25 mg q.i.d. for five days after immunization and the control subjects not receiving indomethacin. In addition, there was no correlation within this group of 40 individuals between three measures of immune function (absolute lymphocyte count, delayed hypersensitivity testing, and response to phytohemagglutinin) and the antibody response to the pneumococcal vaccine.",
author = "Lafferty, {William P.} and Selinger, {Daniel S.} and Gerald Schiffman and James Goodwin",
year = "1981",
doi = "10.3109/08923978109026429",
language = "English",
volume = "3",
pages = "241--250",
journal = "Immunopharmacology and Immunotoxicology",
issn = "0892-3973",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Response to pneumococcal vaccine in the elderly

T2 - No enhancement by indomethacin

AU - Lafferty, William P.

AU - Selinger, Daniel S.

AU - Schiffman, Gerald

AU - Goodwin, James

PY - 1981

Y1 - 1981

N2 - We investigated whether indomethacin administration would augment the antibody response to pneumococcal vaccine in a group of healthy elderly individuals. There was no significant difference in mean increases in antibody levels to 12 pneumococcal polysaccharide types between the 20 subjects who received indomethacin 25 mg q.i.d. for five days after immunization and the control subjects not receiving indomethacin. In addition, there was no correlation within this group of 40 individuals between three measures of immune function (absolute lymphocyte count, delayed hypersensitivity testing, and response to phytohemagglutinin) and the antibody response to the pneumococcal vaccine.

AB - We investigated whether indomethacin administration would augment the antibody response to pneumococcal vaccine in a group of healthy elderly individuals. There was no significant difference in mean increases in antibody levels to 12 pneumococcal polysaccharide types between the 20 subjects who received indomethacin 25 mg q.i.d. for five days after immunization and the control subjects not receiving indomethacin. In addition, there was no correlation within this group of 40 individuals between three measures of immune function (absolute lymphocyte count, delayed hypersensitivity testing, and response to phytohemagglutinin) and the antibody response to the pneumococcal vaccine.

UR - http://www.scopus.com/inward/record.url?scp=84907114865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907114865&partnerID=8YFLogxK

U2 - 10.3109/08923978109026429

DO - 10.3109/08923978109026429

M3 - Article

VL - 3

SP - 241

EP - 250

JO - Immunopharmacology and Immunotoxicology

JF - Immunopharmacology and Immunotoxicology

SN - 0892-3973

IS - 2

ER -